HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Versican expression in tumor epithelial cells is correlated with a good prognosis in gastric cancer.

AbstractBACKGROUND/AIM:
Versican expression has been reported to have prognostic value in several cancers. The aim of the present study was to investigate the prognostic significance of versican expression in gastric cancer.
MATERIALS AND METHODS:
In total, 105 gastric cancer patients who received gastrectomy were included in the study. Versican expression in the epithelial and stromal components of the tumors was determined by immunohistochemistry.
RESULTS:
Versican was expressed in 21.0% of tumor epithelial cells and 44.8% of stromal cells. Patients with versican expression in tumor epithelial cells had significantly better 5-year disease-free (p=0.021) and overall (p=0.034) survival rates, whereas versican expression in stromal cells was not associated with disease-free (p=0.532) and overall (p=0.876) survival. Multivariate analysis showed that versican expression in tumor epithelial cells was an independent prognostic indicator for better clinical outcome in disease-free and overall survival.
CONCLUSION:
Versican expression in tumor epithelial cells predicts a good prognosis for gastric cancer patients.
AuthorsNam Seok Kim, Han Hong Lee, Chan-Kwon Jung, Hae Myung Jeon
JournalAnticancer research (Anticancer Res) Vol. 34 Issue 10 Pg. 5613-9 (Oct 2014) ISSN: 1791-7530 [Electronic] Greece
PMID25275064 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Chemical References
  • Versicans
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Gastric Mucosa (metabolism, pathology)
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Patient Outcome Assessment
  • Prognosis
  • Stomach Neoplasms (genetics, metabolism, mortality, pathology)
  • Versicans (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: